Neutral impactCorporate Action
Piramal Pharma Limited — Shareholders meeting
NSE 3 Jul·3 Jul 2026, 9:50 am
PPLPHARMA NSE
Notice of the 6th Annual General Meeting and Annual Report for the financial year 2025 26
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns PPLPHARMA.
- Category: Corporate Action.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
